Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice.
- DOI
- 10.1016/j.amjcard.2022.11.009
- Published
- 2023 Feb 15
- Container
- The American journal of cardiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.amjcard.2022.11.009,
title = {Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice.},
author = {Zeymer U and Toelg R and Wienbergen H and Hobbach HP and Cuneo A and Bekeredjian R and Ritter O and Hailer B and Hertting K and Hennersdorf M and Scholtz W and Lanzer P and Mudra H and Schwefer M and Schwimmbeck PL and Liebetrau C and Thiele H and Claas C and Riemer T and Zahn R},
year = {2023},
journal = {The American journal of cardiology},
doi = {10.1016/j.amjcard.2022.11.009},
url = {https://doi.org/10.1016/j.amjcard.2022.11.009}
}RIS
TY - JOUR TI - Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice. AU - Zeymer U AU - Toelg R AU - Wienbergen H AU - Hobbach HP AU - Cuneo A AU - Bekeredjian R AU - Ritter O AU - Hailer B AU - Hertting K AU - Hennersdorf M AU - Scholtz W AU - Lanzer P AU - Mudra H AU - Schwefer M AU - Schwimmbeck PL AU - Liebetrau C AU - Thiele H AU - Claas C AU - Riemer T AU - Zahn R PY - 2023 JO - The American journal of cardiology DO - 10.1016/j.amjcard.2022.11.009 UR - https://doi.org/10.1016/j.amjcard.2022.11.009 ER -
APA
U, Z., R, T., H, W., HP, H., A, C., R, B., O, R., B, H., K, H., M, H., W, S., P, L., H, M., M, S., PL, S., C, L., H, T., C, C., T, R., & R, Z. (2023). Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice.. The American journal of cardiology. https://doi.org/10.1016/j.amjcard.2022.11.009
Source records
- pubmed · retrieved 2026-09-26T18:49:54.595Z